Skip to main content
Clinical Trials/NL-OMON44822
NL-OMON44822RecruitingNot Applicable

Biomarker activity and chronic heart failure in adult patients with congenital heart disease. - BioCon

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites602 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
602

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Patients to be included must meet the following criteria:
  • 1. Men and women, aged 18 years or older, capable of understanding and signing informed
  • 2. Patients is known with a congenital heart disease. Cardiac diagnoses are atrial septal defect, ventricular septal defect, pulmonal stenoses, Tetralogy of Fallot, Transposition of the great arteries, eisenmenger syndrome, aortic pathology and Fontan circulation.

Exclusion Criteria

  • Patients living abroad or who were not Dutch speaking.

Investigators

Similar Trials